Tag: EACR
Highlights from the EACR conference ‘Persister Cells: from Bacteria to Cancer’
Dr. Alexandra Boitor, EACR Scientific Officer, gives a few of the scientific highlights from the EACR Conference Persister Cells: from Bacteria to Cancer (Lyon,...
Highlights from the EACR 2024 Liquid Biopsies Conference
Liquid biopsies are demonstrating the potential to support early detection and screening of cancer, as a prognostic tool, to predict treatment efficacy or resistance,...
Highlights from the EACR-AstraZeneca Conference Circulating Nucleic Acids (cfDNA/ctDNA): In use,...
For the EACR, the conference season started this year with a joint EACR-AstraZeneca Conference, Circulating Nucleic Acids (cfDNA/ctDNA): In use, in view and on...
Highlights from the EACR-Boehringer Ingelheim 2025 Conference: Drugging and Regulating the...
After a successful first meeting in 2023, the joint EACR and Boehringer Ingelheim virtual conference returned this year on 11 - 12 February 2025...
Scientific Highlights from ‘Cancer Genomics, Multiomics and Computational Biology’ 2024
The EACR conference on Cancer Genomics, widely recognised as the premier European conference dedicated to this topic, evolved its content in 2024 to cover...
Celebrating 12,000 Members: the EACR Community Grows Stronger
We are thrilled to announce that the European Association for Cancer Research (EACR) has just reached a major milestone - we now have 12,000...
EACR 2022 Congress in review: “the top meeting in Europe with...
A lot has happened since our last in-person Congress in Amsterdam in 2018. After virtual congresses in 2020 and 2021, finally in 2022 we...
More articles
A novel pan-lysyl oxidase inhibitor for improving the treatment of pancreatic...
Dr Jessica Chitty and Dr Thomas Cox generated and validated a novel selective and irreversible pan-lysyl oxidase inhibitor: PXS-5505. Their experiments in a series...
